|Expense Ratio (net)||N/A|
|Last Cap Gain||N/A|
|Morningstar Risk Rating||N/A|
|Beta (5Y Monthly)||N/A|
|5y Average Return||N/A|
|Average for Category||N/A|
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will be strengthening its management team in 2020 through two strategic recruitments. As of January 1, Tomas Odergren will assume the role of Chief Medical Officer and as of May 18, Oskar Bosson will assume the role of VP Communications & IR. Tomas Odergren has significant experience from senior positions including at AstraZeneca, Lundbeck and most recently at BioArctic. Oskar Bosson joins BioArctic from his previous role as Executive Vice President Communication & Public Affairs at Elekta AB.
NEW YORK, NY / ACCESSWIRE / March 16, 2018 / BioAmber, Inc. OTC PINK: BIOA ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 16, 2018, at 8:00 AM Eastern Time. To ...
NEW YORK, NY / ACCESSWIRE / February 26, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...